Baseline (ie, zero years) demographic and clinical characteristics of all patients in the Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA) trial and patients with complete data on 5-year outcome
| Characteristic | CAMERAtotal | DAS28complete | Radiographcomplete | ||
|---|---|---|---|---|---|
| All | TC | CT | TC | CT | |
| n=299 | n=102 | n=103 | n=97 | n=103 | |
| Female gender (%) | 201 (67) | 72 (71) | 66 (64) | 67 (69) | 65 (63) |
| Age (years) | 53 (15) | 54 (13) | 53 (14) | 53 (13) | 52 (14) |
| ESR (mm/h1st) | 37 (26) | 37 (28) | 38 (21) | 36 (28) | 38 (23) |
| CRP (mg/l) | 28 (28) | 28 (31) | 30 (25) | 28 (33) | 30 (27) |
| Rheumatoid factor positive (%) | 185 (62) | 90 (65) | 67 (65) | 65 (67) | 64 (62) |
| Morning stiffness (min) | 92 (61) | 66 (65) | 88 (59) | 95 (66) | 89 (59) |
| VAS general (mm) | 54 (24) | 54 (24) | 54 (23) | 55 (24) | 53 (24) |
| VAS pain (mm) | 51 (27) | 53 (28) | 49 (28) | 53 (28) | 49 (27) |
| TJC | 14 (7) | 15 (7) | 13 (7) | 15 (8) | 14 (7) |
| SJC | 14 (7) | 14 (7) | 14 (6) | 14 (7) | 14 (7) |
| DAS28 | 5.6 (1.1) | 5.6 (1.2) | 5.6 (1.0) | 5.6 (1.1) | 5.6 (1.0) |
| SHS | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
Mean (SD) is shown for all continuous variables, except for SHS where median (IQR) is shown. For all categorical variables number (%) of patients is shown.
CAMERAtotal, data on all patients (intent-to-treat population); CRP, C reactive protein; CRP, C reactive protein; CT, conventional treatment strategy; DAS28, disease activity score, based on 28 joints; ESR, erythrocyte sedimentation rate; SHS, Sharp van der Heijde Score; SJC, swollen joint count, based on 38 joints; TC, tight control treatment strategy; TJC, tender joint count, based on 38 joints; VAS, visual analogue scale.